Details of the Drug

General Information of Drug (ID: DMXYCZV)

Drug Name
AMG 256
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Protein
Cross-matching ID
TTD ID
DHQ9S3

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 21 receptor (IL21R) TTZO9B0 IL21R_HUMAN Agonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04362748) Study of AMG 256 in Adult Subjects With Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Amgen.